focus -WSS

focus

author：entertainment 2025-09-27 13:09:43 - browse：77

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： It costs an awful lot of money to give away a kidney

WSS

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Independent physicians launch a new lobbying group

When waiting feels immoral: Empathy in the emergency department

Copay coupons to count toward deductibles, after Biden court move

Dewpoint Therapeutics lays off staff after losing partnerships

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

focus

focus

explore

Jerome Adams on the need for new antivirals for Covid

My yearlong odyssey to get my son’s ADHD medication covered

Wildfire smoke exposes gaps in outdoor worker protections

Why doctors need education on FDA device approval process

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Guidelines to prevent youth baseball injuries need more muscle

FDA clears AI tool for detecting skin cancer

Medicare proposal to cover medical devices draws a mixed reaction

The cancer stories no one wants to hear

hotspot

Pharma showers House GOP doctor with campaign cash

FDA approves Sage Therapeutics’ rapid

Florida officials tell state schools to teach AP Psychology 'in its entirety'

How digital therapeutics firms are pivoting after Pear's bankruptcy

Humana cuts profit projections as Medicare Advantage costs soar

2 officers injured in shooting in Orlando, police say

focus

Wikipedia

entertainment

entertainment